TRIPS
Oxfam reaction to the WTO decision on the extension of the transition period of TRIPS implementation to LDCs
The poorest nations in the world succeeded in securing a deal to extend the transition period on the implementation of Trade Related Aspects on Intellectual Property Rights (TRIPS) by eight more ye
Crisis of poor quality medicines being used as an excuse to push up prices for poor
Eye on the Ball
Poor-quality, or “substandard”, medicines threaten patients and public health in developing countries.
EU double standards threaten to leave poor countries without medicines
GSK breaks industry ranks to improve access to medicines

Join Oxfam International on social media: